Drug intelligence / Profile preview

dexamethasone + fentanyl

Development stage
Unknown
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Epidural, Intrathecal, Intramuscular
01

Overview

Dexamethasone + fentanyl is a combination of two pharmaceutical agents used primarily in perioperative and postoperative settings to enhance analgesia and reduce opioid-related side effects. Dexamethasone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressant properties, acting mainly by suppressing the release of inflammatory mediators and modulating immune responses. Fentanyl is a potent synthetic opioid analgesic that acts as an agonist at mu, delta, and kappa opioid receptors to provide strong pain relief. When used together, dexamethasone can reduce inflammation-induced pain and postoperative nausea/vomiting (PONV), while fentanyl provides rapid-onset analgesia. Clinical studies have shown that this combination can significantly improve pain control after surgery compared to fentanyl alone, decrease the required dose of opioids, lower pain scores, and reduce the incidence of PONV[2][6]. The combination may also attenuate stress hormone responses during surgery through interactive inhibitory effects on ACTH release[1].

02

Targets

DOR (Opioid Receptor Delta 1)GR (Glucocorticoid receptor)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on dexamethasone + fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + fentanyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call